These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 39071160

  • 1. S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs.
    Li J, Zhou C, Gao X, Tan T, Zhang M, Li Y, Chen H, Wang R, Wang B, Liu J, Liu P.
    Oncoimmunology; 2024; 13(1):2381803. PubMed ID: 39071160
    [Abstract] [Full Text] [Related]

  • 2. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis.
    Deng Z, Rong Y, Teng Y, Zhuang X, Samykutty A, Mu J, Zhang L, Cao P, Yan J, Miller D, Zhang HG.
    Oncogene; 2017 Feb 02; 36(5):639-651. PubMed ID: 27345402
    [Abstract] [Full Text] [Related]

  • 3. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
    Schafer CC, Wang Y, Hough KP, Sawant A, Grant SC, Thannickal VJ, Zmijewski J, Ponnazhagan S, Deshane JS.
    Oncotarget; 2016 Nov 15; 7(46):75407-75424. PubMed ID: 27705910
    [Abstract] [Full Text] [Related]

  • 4. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
    Das SK, Guo C, Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Emdad L, Subler MA, Windle JJ, Sarkar D, Wang XY, Fisher PB.
    Oncotarget; 2016 Jul 26; 7(30):46848-46861. PubMed ID: 27341128
    [Abstract] [Full Text] [Related]

  • 5. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions.
    Liu J, Wu S, Zheng X, Zheng P, Fu Y, Wu C, Lu B, Ju J, Jiang J.
    Sci Rep; 2020 Sep 08; 10(1):14749. PubMed ID: 32901082
    [Abstract] [Full Text] [Related]

  • 6. CXCL17-derived CD11b+Gr-1+ myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB.
    Hsu YL, Yen MC, Chang WA, Tsai PH, Pan YC, Liao SH, Kuo PL.
    Breast Cancer Res; 2019 Feb 12; 21(1):23. PubMed ID: 30755260
    [Abstract] [Full Text] [Related]

  • 7. Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment.
    Rashid MH, Borin TF, Ara R, Piranlioglu R, Achyut BR, Korkaya H, Liu Y, Arbab AS.
    Oncol Rep; 2021 Mar 12; 45(3):1171-1181. PubMed ID: 33469683
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M, Cederberg RA, Hamilton MJ, LePard NE, Harbourne BT, Collier JL, Halvorsen EC, Shi R, Franks SE, Kim AY, Banáth JP, Hamer M, Rossi FM, Bennewith KL.
    Breast Cancer Res; 2019 Sep 05; 21(1):103. PubMed ID: 31488209
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of non-small cell lung cancer metastasis by knocking down APE1 through regulating myeloid-derived suppressor cells-induced immune disorders.
    Zhang Z, Lin Y, Pan X, Chen S.
    Aging (Albany NY); 2024 Jun 14; 16(12):10435-10445. PubMed ID: 38885059
    [Abstract] [Full Text] [Related]

  • 11. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
    Sun L, Clavijo PE, Robbins Y, Patel P, Friedman J, Greene S, Das R, Silvin C, Van Waes C, Horn LA, Schlom J, Palena C, Maeda D, Zebala J, Allen CT.
    JCI Insight; 2019 Apr 04; 4(7):. PubMed ID: 30944253
    [Abstract] [Full Text] [Related]

  • 12. Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer.
    Hoffmann SHL, Reck DI, Maurer A, Fehrenbacher B, Sceneay JE, Poxleitner M, Öz HH, Ehrlichmann W, Reischl G, Fuchs K, Schaller M, Hartl D, Kneilling M, Möller A, Pichler BJ, Griessinger CM.
    Theranostics; 2019 Apr 04; 9(20):5869-5885. PubMed ID: 31534525
    [Abstract] [Full Text] [Related]

  • 13. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
    Zhao N, Zhu W, Wang J, Liu W, Kang L, Yu R, Liu B.
    Int Immunopharmacol; 2021 Oct 04; 99():107924. PubMed ID: 34217145
    [Abstract] [Full Text] [Related]

  • 14. MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation.
    Wang Y, Ding Y, Guo N, Wang S.
    Front Immunol; 2019 Oct 04; 10():172. PubMed ID: 30792719
    [Abstract] [Full Text] [Related]

  • 15. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
    Cresswell GM, Wang B, Kischuk EM, Broman MM, Alfar RA, Vickman RE, Dimitrov DS, Kularatne SA, Sundaram CP, Singhal S, Eruslanov EB, Crist SA, Elzey BD, Ratliff TL, Low PS.
    Cancer Res; 2021 Feb 01; 81(3):671-684. PubMed ID: 33203700
    [Abstract] [Full Text] [Related]

  • 16. PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model.
    Wang T, Jing B, Xu D, Liao Y, Song H, Sun B, Guo W, Xu J, Li K, Hu M, Liu S, Ling J, Kuang Y, Zhang T, Zhang S, Yao F, Zhou BP, Deng J.
    Oncogene; 2020 Apr 01; 39(15):3179-3194. PubMed ID: 32060421
    [Abstract] [Full Text] [Related]

  • 17. E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells.
    Liang M, Sun Z, Chen X, Wang L, Wang H, Qin L, Zhao W, Geng B.
    J Exp Clin Cancer Res; 2023 Oct 21; 42(1):275. PubMed ID: 37865804
    [Abstract] [Full Text] [Related]

  • 18. [S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway].
    Wang H, Sun Z, Zhao W, Geng B.
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May 20; 43(5):733-740. PubMed ID: 37313814
    [Abstract] [Full Text] [Related]

  • 19. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J, Yang L, Yu L, Wang YY, Chen R, Qian J, Hong ZP, Su XS.
    Oncotarget; 2017 Mar 07; 8(10):17050-17058. PubMed ID: 28178645
    [Abstract] [Full Text] [Related]

  • 20. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.
    Wang Y, Schafer CC, Hough KP, Tousif S, Duncan SR, Kearney JF, Ponnazhagan S, Hsu HC, Deshane JS.
    J Immunol; 2018 Jul 01; 201(1):278-295. PubMed ID: 29752311
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.